Job Title: Lead, New Product Commercialization

Location: Waltham, MA

Overview

The New Product Commercialization Lead, is a pivotal role that will support all commercial planning related to the successful commercialization of all complement-mediated pipeline assets in development. This role will be central to defining how to introduce potentially ground-breaking complement therapies to ophthalmology, rare, and neurology disease areas, and will be a core member of the pipeline strategy team, and will report to the VP of Commercial Strategy and Operations.

This position is onsite / hybrid and will be primarily located in Waltham, MA.

Key Responsibilities

• Collaborate with the Research and Development and Business Insights Teams to execute comprehensive market research to identify trends, customer needs, and competitive landscape; Communicate insights on the evolving treatment landscape, patient needs and competitive dynamics across major markets (US, EU, Japan),
•  Support development and execution of a strategy to maximize market potential of identified complement targets, including life cycle management and short, medium- and long-term commercialization plans
• Work with internal teams and external experts including key opinion leaders, regulatory partners, and industry partners to identify and assess potential opportunities/risks and translate key insights into actionable strategies and recommendations for future development plans
• Collaborate closely with R&D leadership, Commercial teams, Manufacturing teams, and cross-functional Pipeline Strategy Team members, in optimizing planning and decision-making while working toward go/no go milestones (including long-range planning and prioritization.   
• Serve as the lead for the commercialization functions on the Pipeline Strategy Team and be the central integrator of information, insights, and perspectives related to commercialization from US and ex-US perspectives
•  Maintain high-level of competitive intelligence within key therapeutic areas of interest including ophthalmology, rare, and neurology.
• Research and articulate future economic and policy trends that may impact commercialization expectations and plan for best- and worst-case scenarios
  
  
  

Qualifications

BA/BS degree required; business degree strongly preferred with strategy/consulting experience; scientific background preferred but not required

• 10+ years of varied biopharmaceutical or related experience, including matrix team responsibilities, with a combined focus on marketing, strategic planning, market access, and product management
• Exceptional written and verbal communication skills. Ability to articulate program vision and motivate the team; communicates in an open, direct and timely manner; ensures broader organization is aligned with and aware of the program strategy, status and risks.
•  Collaborative and team-player who can take on initiatives when needed; uses analytic frameworks to drive team members to important program decisions.
• Strong understanding of the drug development, lifecycle and regulatory processes
• Proven track record of successfully launching and commercializing products within US and ex-US countries  
• Experience in rare, ophthalmology, nephrology, and/or neurology preferred.   
•  Proven ability to influence in cross-functional settings and be a catalyst for organizational change a must.

Benefits and Perks:

Apellis offers a comprehensive benefits package, including a 401(k) plan with company match, inclusive family building benefits, flexible time off, summer and winter shutdowns, paid family leave, disability and life insurance, and more! Visit https://apellis.com/careers/ to learn more.

Company Background:

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.

For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn

EEO Statement:

Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumoconiosis or any other characteristic protected under applicable federal, state or local law.

For San Francisco postings: Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records.  

Other Duties:

Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice.